These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 16012920)

  • 21. Autonomic cardiovascular function and baroreflex sensitivity in patients with cervical dystonia receiving treatment with botulinum toxin type A.
    Tiple D; Strano S; Colosimo C; Fabbrini G; Calcagnini G; Prencipe M; Berardelli A
    J Neurol; 2008 Jun; 255(6):843-7. PubMed ID: 18458860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and tolerability of botulinum toxin type A in patients with neurogenic detrusor overactivity and without concomitant anticholinergic therapy: comparison of two doses.
    Grise P; Ruffion A; Denys P; Egon G; Chartier Kastler E
    Eur Urol; 2010 Nov; 58(5):759-66. PubMed ID: 20674149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Side effects of intradetrusor botulinum toxin injections on ejaculation and fertility in men with spinal cord injury: preliminary findings.
    Caremel R; Courtois F; Charvier K; Ruffion A; Journel NM
    BJU Int; 2012 Jun; 109(11):1698-702. PubMed ID: 21981647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Uncommon foreign body reaction caused by botulinum toxin.
    Pontes HA; Pontes FS; de Oliveira GF; de Almeida HA; Guimarães DM; Cavallero FC
    J Craniofac Surg; 2012 Jul; 23(4):e303-5. PubMed ID: 22801160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patient-reported side effects of intradetrusor botulinum toxin type a for idiopathic overactive bladder syndrome.
    Bauer RM; Gratzke C; Roosen A; Hocaoglu Y; Mayer ME; Buchner A; Stief CG; May F
    Urol Int; 2011; 86(1):68-72. PubMed ID: 20639617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early communication about an ongoing safety review Botox and Botox Cosmetic (botulinum toxin type A) and Myobloc (botulinum toxin type B).
    U.S. Food and Drug Administration
    Plast Surg Nurs; 2008; 28(3):150-1. PubMed ID: 18794742
    [No Abstract]   [Full Text] [Related]  

  • 27. The emerging role of intravesical botulinum toxin therapy in idiopathic detrusor overactivity.
    Patel AK; Patterson JM; Chapple CR
    Int J Clin Pract Suppl; 2006 Dec; (151):27-32. PubMed ID: 17169008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adverse events of intravesical botulinum toxin a injections for idiopathic detrusor overactivity: risk factors and influence on treatment outcome.
    Kuo HC; Liao CH; Chung SD
    Eur Urol; 2010 Dec; 58(6):919-26. PubMed ID: 20864251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Persistence of Upper Blepharoptosis After Cosmetic Botulinum Toxin Type A.
    Steinsapir KD; Groth MJ; Boxrud CA
    Dermatol Surg; 2015 Jul; 41(7):833-40. PubMed ID: 26057409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Botulinum toxin-B and the management of hyperhidrosis.
    Baumann LS; Halem ML
    Clin Dermatol; 2004; 22(1):60-5. PubMed ID: 15158547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Botulinum toxin injection causing lateral rectus palsy.
    Chen CS; Miller NR
    Br J Ophthalmol; 2007 Jun; 91(6):843. PubMed ID: 17510486
    [No Abstract]   [Full Text] [Related]  

  • 32. BotB (botulinum toxin type B): evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study).
    Truong DD; Cullis PA; O'Brien CF; Koller M; Villegas TP; Wallace JD
    Mov Disord; 1997 Sep; 12(5):772-5. PubMed ID: 9380065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adverse events after botulinum A toxin injection for neurogenic voiding disorders.
    De Laet K; Wyndaele JJ
    Spinal Cord; 2005 Jul; 43(7):397-9. PubMed ID: 15741978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prophylactic botulinum type A toxin complex (Dysport®) for migraine without aura.
    Chankrachang S; Arayawichanont A; Poungvarin N; Nidhinandana S; Boonkongchuen P; Towanabut S; Sithinamsuwan P; Kongsaengdao S
    Headache; 2011 Jan; 51(1):52-63. PubMed ID: 21083558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Botulinum toxin injection into the superior rectus for treatment of strabismus.
    Dawson E; Ali N; Lee JP
    Strabismus; 2012 Mar; 20(1):24-5. PubMed ID: 22390328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improvement in pelvic pain with botulinum toxin type A - Single vs. repeat injections.
    Nesbitt-Hawes EM; Won H; Jarvis SK; Lyons SD; Vancaillie TG; Abbott JA
    Toxicon; 2013 Mar; 63():83-7. PubMed ID: 23220489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute myocardial infarction after botulinum toxin injection.
    Stähli BE; Altwegg L; Lüscher TF; Corti R
    QJM; 2011 Jul; 104(7):615-6. PubMed ID: 20851822
    [No Abstract]   [Full Text] [Related]  

  • 38. Long-term safety, efficacy, dosing, and development of resistance with botulinum toxin type B in cervical dystonia.
    Berman B; Seeberger L; Kumar R
    Mov Disord; 2005 Feb; 20(2):233-7. PubMed ID: 15455449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of apraclonidine eyedrops to treat ptosis after the administration of botulinum toxin to the upper face.
    Scheinfeld N
    Dermatol Online J; 2005 Mar; 11(1):9. PubMed ID: 15748550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The first documented case of true botulinum toxin granuloma.
    Yun WJ; Kim JK; Kim BW; Lee SK; Kim YJ; Lee MW; Chang SE
    J Cosmet Laser Ther; 2013 Dec; 15(6):345-7. PubMed ID: 23607737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.